Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials
The answer is not as simple as yes or no
Mutants of the candidate residues were subsequently compared with wild-type ScGrx7 in steady-state kinetic measurements using HEDS and GSSCys as a non-glutathione and glutathione disulfide substrate, respectively
doi:10.1016/j.ddmec.2009.02.001 Higdon J
doi:10.1007/s00441-019-03016-8 Mayfield CK, Bolia IK, Feingold CL, et al
US$ 28.93
US$ 24.83
US$ 26.66
